Why Under-Eye Filler Can Swell Months Later: The Malar Edema Problem Explained

Of all the complications associated with under-eye filler, delayed swelling is the one patients least expect. The injection heals, the result looks good for weeks or even months, and then a soft, spongy fullness appears over the cheekbone or just under the lower lid. It can worsen in the morning, after salty food, after alcohol, or during allergy season. Clinicians call it malar edema, and it is one of the most common reasons people end up dissolving tear trough filler. Understanding why it happens requires three pieces of background: the anatomy of the region, the chemistry of hyaluronic acid, and the mechanics of injection depth.

The anatomy: a poorly drained neighborhood. The area below the eye, roughly the triangle over the upper cheek, drains lymphatic fluid less efficiently than almost anywhere else on the face. A fibrous structure often described as the malar septum, running from the orbital rim down through the cheek tissue, acts like a low dam. Fluid that accumulates above it has limited routes out. This is why some people develop puffiness or festoons in this zone with no filler at all, simply from age, sun damage, allergies, or thyroid conditions. Anything that adds volume or obstructs drainage in this compartment tends to show up as visible swelling, and it tends to persist.

The chemistry: hyaluronic acid is hygroscopic. Hyaluronic acid, the material in nearly all tear trough fillers, is prized precisely because it binds water. A single gram can hold many times its weight in water molecules. That property creates smooth, natural volume in most of the face. Under the eye, where skin is thin and drainage is slow, it becomes a liability. A filler placed there does not just occupy its injected volume. It continues to attract and hold water, and the degree to which it does so depends on the specific product. Fillers with higher hydrophilicity, generally softer gels with certain crosslinking profiles, swell more. This is why experienced injectors choose low-swelling, moderately cohesive products for this region and avoid gels designed for cheeks or lips.

The mechanics: depth decides drainage. The lymphatic vessels that drain the under-eye region run relatively superficially, above the orbicularis muscle and within the immediate subdermal tissue. Filler placed too superficially, in or just under the skin, can physically compress or obstruct these small channels. Filler placed deep, directly on the bone beneath the muscle, largely avoids them. This is the single most important technical variable. The same product, in the same patient, can behave completely differently depending on whether it sits above or below the muscle plane. Deep, supraperiosteal placement in small amounts is the widely taught standard for this reason, though even correct placement does not guarantee immunity in a patient with poor baseline drainage.

Why it shows up late. Delayed onset confuses patients, but it fits the mechanism. Hyaluronic acid absorbs water gradually. Lymphatic obstruction produces fluid accumulation slowly, not overnight. And as filler degrades over months, fragments can migrate slightly or shift within tissue planes, changing how they interact with drainage pathways. Some patients also develop low-grade inflammatory responses to filler months after injection, often triggered by illness or dental work, which adds an immune-mediated swelling component on top of the fluid problem. A puffy under-eye appearing six to eighteen months after treatment is frequently the filler itself, still present and still holding water, even when the patient assumes it dissolved long ago. Imaging studies have repeatedly found hyaluronic acid persisting in the tear trough for years beyond its advertised lifespan.

Who is at higher risk. Patients with existing festoons or morning puffiness, thin skin, a history of allergies or sinus issues, thyroid eye involvement, or prior filler in the same area carry elevated risk. A careful assessment includes asking whether the patient already swells in that zone. If the answer is yes, filler is likely to amplify the problem rather than camouflage it, and many clinicians will decline to treat or will redirect toward cheek support, skin treatments, or surgical consultation instead.

What actually fixes it. Conservative measures, such as head elevation at night, reduced sodium, and gentle lymphatic massage, help mildly and temporarily. The definitive treatment is hyaluronidase, the enzyme that breaks down hyaluronic acid. Because the swelling is driven by water bound to residual gel, removing the gel removes the fluid reservoir. Dissolving may take more than one session, since old, integrated filler responds more slowly than fresh product. Patients are sometimes reluctant because dissolving temporarily returns the hollow they originally treated, but persistent malar edema rarely resolves while the filler remains.

The practical takeaway: delayed under-eye swelling after filler is a mechanical and chemical problem with a known cause, not a mystery. Product choice, injection depth, conservative volume, and honest patient selection prevent most cases. For those already dealing with it, the path forward usually runs through dissolving, not waiting.

Related reading: Why Under-Eye Filler Can Puff Up Months Later: The Water-Binding Problem, Explained.